Abivax and Scripps Research Announce FDA Approval to Initiate a Phase 1/2 Clinical Trial with ABX196 in Patients with Hepatocellular Carcinoma

Written by Petra Hegmann on 13th May 2019. Posted in Client News.

• Previous
• Next